The International Tobacco Control Framework: Why Global Governance Fails the Poorest Smokers

The WHO Framework Convention on Tobacco Control was supposed to be the great equalizer—a global treaty that would give low- and middle-income countries the tools and the political cover to resist the tobacco industry's expansion into their markets. It was designed to prevent exactly what's happening: the industry, facing declining sales in high-income countries, aggressively targeting LMICs with the same marketing, lobbying, and product design strategies that built the smoking epidemic in the West. Twenty years after the FCTC entered into force, the epidemic is shifting south and east as predicted—but the treaty hasn't stopped it. The implementation gap between treaty ratification and on-the-ground enforcement is vast, and it's widest in the countries that need the treaty most. Why is the international tobacco control framework failing the world's poorest smokers, and what would it take to fix it?

The first failure is capacity. The FCTC is a framework convention—it sets out principles and obligations, but implementation depends on national legislation, regulatory capacity, and enforcement resources. For a low-income country with limited administrative capacity, competing health priorities (maternal mortality, infectious disease, malnutrition), and a powerful tobacco industry that provides tax revenue and agricultural employment, the gap between ratifying the FCTC and implementing its provisions is vast. The treaty provides technical assistance and normative pressure, but it doesn't provide the funding, personnel, or institutional infrastructure that implementation requires. The FCTC Secretariat's budget is a rounding error compared to the revenues of any single major tobacco company. The international community has been willing to create a legal framework for tobacco control. It has been less willing to fund its implementation in the countries that need it most.

The second failure is the exclusion of harm reduction. The FCTC was negotiated in an era when 'tobacco product' meant combustible cigarettes, and its provisions are oriented toward that reality. When novel nicotine products—e-cigarettes, heated tobacco, nicotine pouches—emerged, the FCTC's institutional response was shaped by the precautionary principle and the treaty's adversarial relationship with the tobacco industry. These products, regardless of their risk profile, were treated as threats to be contained rather than as potentially reduced-risk alternatives to be evaluated. The result is that the FCTC provides no guidance—and, in practice, active discouragement—for LMICs considering harm-reduction strategies. This is consequential because the populations that could benefit most from switching to non-combustible products—smokers in LMICs who lack access to cessation services and face the highest burden of smoking-related disease—are denied a policy option that could save millions of lives, largely because the institutional framework wasn't designed to accommodate it.

The third failure is industry interference. The FCTC includes Article 5.3, which requires parties to protect public health policies from tobacco industry interests—a groundbreaking provision that recognizes the fundamental conflict between the industry's interests and public health. But Article 5.3 has no enforcement mechanism, and the industry's strategies for circumventing it have evolved faster than the implementation guidelines. In LMICs, the industry deploys the full arsenal of tactics it developed in high-income countries: funding political campaigns, cultivating relationships with finance and agriculture ministries (which prioritize tobacco revenue over health), deploying corporate social responsibility programs that buy political protection, and threatening litigation through trade and investment agreements. Against this onslaught, the FCTC offers guidelines, technical assistance, and moral authority. It doesn't offer the economic counterweights—alternative revenue sources, farmer transition programs, legal defense funds—that would give LMIC governments the capacity to resist. The treaty asks countries to prioritize health over economics without helping them solve the economic problem.

The fourth failure is structural adjustment and trade policy. International financial institutions—the IMF, the World Bank, regional development banks—have historically promoted policies (privatization of state tobacco monopolies, trade liberalization, reduction of tariffs on tobacco products) that increase tobacco consumption in LMICs, even as the WHO promotes policies that reduce it. The FCTC has no authority over these institutions, and tobacco control is not systematically integrated into development finance or trade policy. A country that receives a World Bank loan conditional on reducing trade barriers may find that the loan's conditions open its market to tobacco imports that its FCTC obligations are supposed to restrict. The international governance architecture is internally contradictory: the health framework pushes in one direction, the economic framework pushes in another, and the poorest countries are caught in the middle.

Fixing the international tobacco control framework requires more than better implementation of the FCTC—though that's essential. It requires integrating tobacco control into the broader development agenda, so that the economic dimensions of tobacco (tax revenue, employment, trade) are addressed alongside the health dimensions. It requires funding implementation in LMICs at a scale that's commensurate with the disease burden, not the symbolic levels that currently characterize international tobacco control assistance. It requires engaging with the evidence on harm reduction, so that LMICs are not denied a policy option that could accelerate smoking cessation in populations where cessation services are scarce. And it requires confronting the structural power of the tobacco industry in the international economic order—through trade agreements that preserve policy space for health regulation, through development finance that doesn't promote tobacco consumption, and through international cooperation that makes it harder, not easier, for the industry to exploit the gap between rich and poor countries.

The FCTC is not a failure. It's an achievement—the first global health treaty, a framework that has accelerated tobacco control policy adoption in countries that would otherwise have taken decades longer to act. But it's an achievement that's been overtaken by the scale of the challenge it was designed to address. The tobacco epidemic is growing in the countries that signed the treaty to protect themselves from it. The industry has adapted to the treaty's provisions faster than the treaty has adapted to the industry's strategies. And the international community's commitment to tobacco control, measured in funding and political capital, has not matched the treaty's ambition. The FCTC was designed for a world where tobacco control was primarily a national challenge with international coordination. The challenge is now global in structure—industry, trade, finance, supply chains—and the response needs to be global in structure too. The treaty is necessary. It's not sufficient. And the gap between necessary and sufficient is measured in the lungs of the world's poorest smokers.